Company Overview of Satoris, Inc.
Satoris, Inc., a molecular diagnostics company, engages in the development and commercialization of neurodiagnostic tests for Alzheimer's disease. It uses molecular biology and bioinformatics to develop diagnostic tests for the management and treatment of neurodegenerative diseases. The company’s products include dementia discrimination panel, a biomarker panel for use in clinical research trials, and patient recruitment and stratification; and neuro61 and neuro77 biomarker panels that are offered as service-based tests including plasma proteins. Satoris, Inc. was founded in 2003 and is based in Redwood City, California.
2686 Middlefield Road
Redwood City, CA 94063
Founded in 2003
Key Executives for Satoris, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact Satoris, Inc., please visit www.satorisinc.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.